GI
DRUG

GAMMA Investing’s Bright Minds Biosciences DRUG Stock Holding History

GAMMA Investing’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Sell
20
-13
-39% -$1.02K ﹤0.01% 3801
2026
Q1 		$2.41K Buy
+33
New +$2.66K ﹤0.01% 3611

GAMMA Investing's DRUG Position: Q2 2026 in Review

GAMMA Investing reduced its Bright Minds Biosciences (DRUG) stake by 39% in Q2 2026, selling an estimated $1.02K and leaving 20 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3801.

GAMMA Investing first reported a position in DRUG in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.41K in Q1 2026. 1 fund tracked by Wall St. Rank holds DRUG as of Q2 2026.

  • GAMMA Investing held 20 shares of Bright Minds Biosciences worth $1.4K as of Q2 2026.
  • GAMMA Investing sold 13 Bright Minds Biosciences shares in Q2 2026, an estimated $1.02K.
  • Bright Minds Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3801 holding.
  • GAMMA Investing first reported a position in Bright Minds Biosciences in Q1 2026 and has held it in 2 quarters since.
  • GAMMA Investing's Bright Minds Biosciences position peaked at $2.41K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.